Stock ELTX ELICIO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Elicio Therapeutics, Inc.

Equities

ELTX

US28657F1030

End-of-day quote Nasdaq
Other stock markets
 03:30:00 23/05/2024 am IST 		5-day change 1st Jan Change
8.85 USD -0.11% Intraday chart for Elicio Therapeutics, Inc. -5.65% +6.12%
23/05 Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-Driven Solid Tumors at the 2024 ASCO Annual Meeting CI
05/04 Elicio Therapeutics, Inc. to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing Amplify-201 Phase 1 Study of ELI-002 and ElI-008 at the AACR Annual Meeting CI

Evolution of the average Target Price on Elicio Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fff947f0eddbe559359036.1Y7FbpqGwyIOhbnj1wXIF08TkcDuWmfO7BMca67PVec.m8CzJqK3tlBD58uo4Fy6cAZ9waW7AlOUj0AuHc_4LNPtxYclrtyme1G07A~11cca5209e8edc65af1bd1ee7e4e6328

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.85 USD
Average target price
10 USD
Spread / Average Target
+12.99%
High Price Target
10 USD
Spread / Highest target
+12.99%
Low Price Target
10 USD
Spread / Lowest Target
+12.99%

Consensus detail

Consensus revision (last 18 months)

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ELTX Stock
  4. Consensus Elicio Therapeutics, Inc.